XML 20 R31.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Commitments and Contingencies (Details) (Abbott Biotherapeutics Corp [Member], USD $) | 6 Months Ended
--- | ---
Jun. 30, 2014
Phase I Clinical Trial of a licensed product [Member] |
Summary of milestone payment |
Milestones payments | $ 750,000
Phase II Clinical Trial of a licensed product [Member] |
Summary of milestone payment |
Milestones payments | 750,000
Phase III Clinical Trial of a licensed product [Member] |
Summary of milestone payment |
Milestones payments | 1,500,000
Biological License Application filing with U.S. FDA [Member] |
Summary of milestone payment |
Milestones payments | 1,750,000
First Commercial Sale [Member] |
Summary of milestone payment |
Milestones payments | 1,500,000
After First Net Sales [Member] |
Summary of milestone payment |
Milestones payments | $ 1,500,000

X
- Definition Long term purchase commitment milestones payment. + References No definition available. + Details
Name: | atnm_LongTermPurchaseCommitmentMilestonesPayment
Namespace Prefix: | atnm_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | atnm_MilestonePaymentAbstract
Namespace Prefix: | atnm_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration